\contentsline {chapter}{Glossary}{xi}{section*.4}
\contentsline {chapter}{Acronyms}{xii}{section*.6}
\contentsline {chapter}{\numberline {1}Introduction and Literature Review}{1}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer Research in the Post-Genomic Era}{1}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Cancer is a Global Health Issue}{2}{subsection.1.1.1}
\contentsline {subsubsection}{\numberline {1.1.1.1}The Genetics and Molecular Biology of Cancers}{3}{subsubsection.1.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}The Genomics Revolution in Cancer Research}{4}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}High-Throughput Technologies}{4}{subsubsection.1.1.2.1}
\contentsline {subsubsection}{\numberline {1.1.2.2}Bioinformatics and Genomics Data}{6}{subsubsection.1.1.2.2}
\contentsline {subsection}{\numberline {1.1.3}Genomics Projects}{6}{subsection.1.1.3}
\contentsline {subsubsection}{\numberline {1.1.3.1}The Cancer Genome Project}{6}{subsubsection.1.1.3.1}
\contentsline {subsubsection}{\numberline {1.1.3.2}The Cancer Genome Atlas Project}{7}{subsubsection.1.1.3.2}
\contentsline {subsection}{\numberline {1.1.4}Genomic Cancer Medicine}{8}{subsection.1.1.4}
\contentsline {subsubsection}{\numberline {1.1.4.1}Cancer Genes and Driver Mutations}{9}{subsubsection.1.1.4.1}
\contentsline {subsubsection}{\numberline {1.1.4.2}Precision Cancer Medicine}{10}{subsubsection.1.1.4.2}
\contentsline {subsubsection}{\numberline {1.1.4.3}Molecular Diagnostics and Pan-Cancer Medicine}{10}{subsubsection.1.1.4.3}
\contentsline {subsubsection}{\numberline {1.1.4.4}Targeted Therapeutics and Pharmacogenomics}{10}{subsubsection.1.1.4.4}
\contentsline {subsection}{\numberline {1.1.5}Systems and Network Biology}{11}{subsection.1.1.5}
\contentsline {subsubsection}{\numberline {1.1.5.1}Network Medicine and Polypharmacology}{13}{subsubsection.1.1.5.1}
\contentsline {section}{\numberline {1.2}A Synthetic Lethal Approach to Cancer Medicine}{14}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Synthetic Lethal Genetic Interactions}{14}{subsection.1.2.1}
\contentsline {subsection}{\numberline {1.2.2}Synthetic Lethal Concepts in Genetics}{15}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}Synthetic Lethality in Model Systems}{16}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Synthetic Lethal Pathways and Networks}{16}{subsubsection.1.2.3.1}
\contentsline {subsubsection}{\numberline {1.2.3.2}Evolution of Synthetic Lethality}{17}{subsubsection.1.2.3.2}
\contentsline {subsection}{\numberline {1.2.4}Synthetic Lethality in Cancer}{18}{subsection.1.2.4}
\contentsline {subsection}{\numberline {1.2.5}Clinical Impact of Synthetic Lethality in Cancer}{19}{subsection.1.2.5}
\contentsline {subsection}{\numberline {1.2.6}High{}-throughput Screening for Synthetic Lethality}{21}{subsection.1.2.6}
\contentsline {subsubsection}{\numberline {1.2.6.1}Synthetic Lethal Screens}{22}{subsubsection.1.2.6.1}
\contentsline {subsection}{\numberline {1.2.7}Computational Prediction of Synthetic Lethality}{25}{subsection.1.2.7}
\contentsline {subsubsection}{\numberline {1.2.7.1}Bioinformatics Approaches to Genetic Interactions}{25}{subsubsection.1.2.7.1}
\contentsline {subsubsection}{\numberline {1.2.7.2}Comparative Genomics}{26}{subsubsection.1.2.7.2}
\contentsline {subsubsection}{\numberline {1.2.7.3}Analysis and Modelling of Protein Data}{29}{subsubsection.1.2.7.3}
\contentsline {subsubsection}{\numberline {1.2.7.4}Differential Gene Expression}{31}{subsubsection.1.2.7.4}
\contentsline {subsubsection}{\numberline {1.2.7.5}Data Mining and Machine Learning}{32}{subsubsection.1.2.7.5}
\contentsline {subsubsection}{\numberline {1.2.7.6}Mutually Exclusive Bimodality}{35}{subsubsection.1.2.7.6}
\contentsline {subsubsection}{\numberline {1.2.7.7}Rationale for Further Development}{35}{subsubsection.1.2.7.7}
\contentsline {section}{\numberline {1.3}E-cadherin as a Synthetic Lethal Target}{36}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}The \textit {CDH1} gene and its Biological Functions}{36}{subsection.1.3.1}
\contentsline {subsubsection}{\numberline {1.3.1.1}Cytoskeleton}{36}{subsubsection.1.3.1.1}
\contentsline {subsubsection}{\numberline {1.3.1.2}Extracellular and Tumour Micro-environment}{37}{subsubsection.1.3.1.2}
\contentsline {subsubsection}{\numberline {1.3.1.3}Cell-Cell Adhesion and Signalling}{37}{subsubsection.1.3.1.3}
\contentsline {subsection}{\numberline {1.3.2}\textit {CDH1} as a Tumour (and Invasion) Suppressor}{37}{subsection.1.3.2}
\contentsline {subsubsection}{\numberline {1.3.2.1}Breast Cancers and Invasion}{38}{subsubsection.1.3.2.1}
\contentsline {subsection}{\numberline {1.3.3}Hereditary Diffuse Gastric Cancer and Lobular Breast Cancer}{38}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Cell Line Models of \textit {CDH1} Null Mutations}{39}{subsection.1.3.4}
\contentsline {section}{\numberline {1.4}Summary and Research Direction of Thesis}{40}{section.1.4}
\contentsline {subsection}{\numberline {1.4.1}Thesis Aims}{42}{subsection.1.4.1}
\contentsline {chapter}{\numberline {2}Methods and Resources}{43}{chapter.2}
\contentsline {section}{\numberline {2.1}Bioinformatics Resources for Genomics Research}{43}{section.2.1}
\contentsline {subsection}{\numberline {2.1.1}Public Data and Software Packages}{43}{subsection.2.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.1}Cancer Genome Atlas Data}{44}{subsubsection.2.1.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.2}Reactome and Annotation Data}{45}{subsubsection.2.1.1.2}
\contentsline {section}{\numberline {2.2}Data Handling}{45}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Normalisation}{45}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Sample Triage}{46}{subsection.2.2.2}
\contentsline {subsection}{\numberline {2.2.3}Metagenes and the Singular Value Decomposition}{48}{subsection.2.2.3}
\contentsline {subsubsection}{\numberline {2.2.3.1}Candidate Triage and Integration with Screen Data}{48}{subsubsection.2.2.3.1}
\contentsline {section}{\numberline {2.3}Techniques}{49}{section.2.3}
\contentsline {subsection}{\numberline {2.3.1}Statistical Procedures and Tests}{49}{subsection.2.3.1}
\contentsline {subsection}{\numberline {2.3.2}Gene Set Over-representation Analysis}{50}{subsection.2.3.2}
\contentsline {subsection}{\numberline {2.3.3}Clustering}{50}{subsection.2.3.3}
\contentsline {subsection}{\numberline {2.3.4}Heatmap}{51}{subsection.2.3.4}
\contentsline {subsection}{\numberline {2.3.5}Modeling and Simulations}{51}{subsection.2.3.5}
\contentsline {subsubsection}{\numberline {2.3.5.1}Receiver Operating Characteristic (Performance)}{52}{subsubsection.2.3.5.1}
\contentsline {subsection}{\numberline {2.3.6}Resampling Analysis}{52}{subsection.2.3.6}
\contentsline {section}{\numberline {2.4}Pathway Structure Methods}{53}{section.2.4}
\contentsline {subsection}{\numberline {2.4.1}Network and Graph Analysis}{53}{subsection.2.4.1}
\contentsline {subsection}{\numberline {2.4.2}Sourcing Graph Structure Data}{54}{subsection.2.4.2}
\contentsline {subsection}{\numberline {2.4.3}Constructing Pathway Subgraphs}{55}{subsection.2.4.3}
\contentsline {subsection}{\numberline {2.4.4}Network Analysis Metrics}{55}{subsection.2.4.4}
\contentsline {section}{\numberline {2.5}Implementation}{56}{section.2.5}
\contentsline {subsection}{\numberline {2.5.1}Computational Resources and Linux Utilities}{56}{subsection.2.5.1}
\contentsline {subsection}{\numberline {2.5.2}R Language and Packages}{57}{subsection.2.5.2}
\contentsline {subsection}{\numberline {2.5.3}High Performance and Parallel Computing}{60}{subsection.2.5.3}
\contentsline {chapter}{\numberline {3}Methods Developed During Thesis}{62}{chapter.3}
\contentsline {section}{\numberline {3.1}A Synthetic Lethal Detection Methodology}{62}{section.3.1}
\contentsline {section}{\numberline {3.2}Synthetic Lethal Simulation and Modelling}{65}{section.3.2}
\contentsline {subsection}{\numberline {3.2.1}A Model of Synthetic Lethality in Expression Data}{65}{subsection.3.2.1}
\contentsline {subsection}{\numberline {3.2.2}Simulation Procedure}{69}{subsection.3.2.2}
\contentsline {section}{\numberline {3.3}Detecting Simulated Synthetic Lethal Partners}{72}{section.3.3}
\contentsline {subsection}{\numberline {3.3.1}Binomial Simulation of Synthetic lethality}{72}{subsection.3.3.1}
\contentsline {subsection}{\numberline {3.3.2}Multivariate Normal Simulation of Synthetic lethality}{74}{subsection.3.3.2}
\contentsline {subsubsection}{\numberline {3.3.2.1}Multivariate Normal Simulation with Correlated Genes}{77}{subsubsection.3.3.2.1}
\contentsline {subsubsection}{\numberline {3.3.2.2}Specificity with Query-Correlated Pathways}{84}{subsubsection.3.3.2.2}
\contentsline {subsubsection}{\numberline {3.3.2.3}Importance of Directional Testing}{84}{subsubsection.3.3.2.3}
\contentsline {section}{\numberline {3.4}Graph Structure Methods}{86}{section.3.4}
\contentsline {subsection}{\numberline {3.4.1}Upstream and Downstream Gene Detection}{86}{subsection.3.4.1}
\contentsline {subsubsection}{\numberline {3.4.1.1}Permutation Analysis for Statistical Significance}{87}{subsubsection.3.4.1.1}
\contentsline {subsubsection}{\numberline {3.4.1.2}Hierarchy Based on Biological Context}{88}{subsubsection.3.4.1.2}
\contentsline {subsection}{\numberline {3.4.2}Simulating Gene Expression from Graph Structures}{89}{subsection.3.4.2}
\contentsline {section}{\numberline {3.5}Customised Functions and Packages Developed}{93}{section.3.5}
\contentsline {subsection}{\numberline {3.5.1}Synthetic Lethal Interaction Prediction Tool}{93}{subsection.3.5.1}
\contentsline {subsection}{\numberline {3.5.2}Data Visualisation}{94}{subsection.3.5.2}
\contentsline {subsection}{\numberline {3.5.3}Extensions to the iGraph Package}{97}{subsection.3.5.3}
\contentsline {subsubsection}{\numberline {3.5.3.1}Sampling Simulated Data from Graph Structures}{97}{subsubsection.3.5.3.1}
\contentsline {subsubsection}{\numberline {3.5.3.2}Plotting Directed Graph Structures}{97}{subsubsection.3.5.3.2}
\contentsline {subsubsection}{\numberline {3.5.3.3}Computing Information Centrality}{98}{subsubsection.3.5.3.3}
\contentsline {subsubsection}{\numberline {3.5.3.4}Testing Pathway Structure with Permutation Testing}{98}{subsubsection.3.5.3.4}
\contentsline {subsubsection}{\numberline {3.5.3.5}Metapackage to Install iGraph Functions}{99}{subsubsection.3.5.3.5}
\contentsline {chapter}{\numberline {4}Synthetic Lethal Analysis of Gene Expression Data}{100}{chapter.4}
\contentsline {section}{\numberline {4.1}Synthetic Lethal Genes in Breast Cancer}{101}{section.4.1}
\contentsline {subsection}{\numberline {4.1.1}Synthetic Lethal Pathways in Breast Cancer}{103}{subsection.4.1.1}
\contentsline {subsection}{\numberline {4.1.2}Expression Profiles of Synthetic Lethal Partners}{104}{subsection.4.1.2}
\contentsline {subsubsection}{\numberline {4.1.2.1}Subgroup Pathway Analysis}{107}{subsubsection.4.1.2.1}
\contentsline {section}{\numberline {4.2}Comparing Synthetic Lethal Gene Candidates}{110}{section.4.2}
\contentsline {subsection}{\numberline {4.2.1}Primary siRNA Screen Candidates}{110}{subsection.4.2.1}
\contentsline {subsection}{\numberline {4.2.2}Comparison with Correlation}{111}{subsection.4.2.2}
\contentsline {subsection}{\numberline {4.2.3}Comparison with Primary Screen Viability}{113}{subsection.4.2.3}
\contentsline {subsection}{\numberline {4.2.4}Comparison with Secondary siRNA Screen Validation}{114}{subsection.4.2.4}
\contentsline {subsection}{\numberline {4.2.5}Comparison to Primary Screen at Pathway Level}{116}{subsection.4.2.5}
\contentsline {subsubsection}{\numberline {4.2.5.1}Resampling Genes for Pathway Enrichment}{118}{subsubsection.4.2.5.1}
\contentsline {subsection}{\numberline {4.2.6}Integrating Synthetic Lethal Pathways and Screens}{121}{subsection.4.2.6}
\contentsline {section}{\numberline {4.3}Metagene Analysis}{123}{section.4.3}
\contentsline {subsection}{\numberline {4.3.1}Pathway Expression}{124}{subsection.4.3.1}
\contentsline {subsection}{\numberline {4.3.2}Somatic Mutation}{126}{subsection.4.3.2}
\contentsline {subsection}{\numberline {4.3.3}Synthetic Lethal Pathway Metagenes}{130}{subsection.4.3.3}
\contentsline {subsection}{\numberline {4.3.4}Synthetic Lethality in Breast Cancer}{131}{subsection.4.3.4}
\contentsline {section}{\numberline {4.4}Replication in Stomach Cancer}{132}{section.4.4}
\contentsline {section}{\numberline {4.5}Discussion}{133}{section.4.5}
\contentsline {subsection}{\numberline {4.5.1}Strengths of the SLIPT Methodology}{133}{subsection.4.5.1}
\contentsline {subsection}{\numberline {4.5.2}Synthetic Lethal Pathways for E-cadherin}{134}{subsection.4.5.2}
\contentsline {subsection}{\numberline {4.5.3}Replication and Validation}{136}{subsection.4.5.3}
\contentsline {subsubsection}{\numberline {4.5.3.1}Integration with siRNA Screening}{136}{subsubsection.4.5.3.1}
\contentsline {subsubsection}{\numberline {4.5.3.2}Replication across Tissues}{137}{subsubsection.4.5.3.2}
\contentsline {section}{\numberline {4.6}Summary}{137}{section.4.6}
\contentsline {chapter}{\numberline {5}Synthetic Lethal Pathway Structure}{139}{chapter.5}
\contentsline {section}{\numberline {5.1}Synthetic Lethal Genes in Reactome Pathways}{139}{section.5.1}
\contentsline {subsection}{\numberline {5.1.1}The PI3K/AKT Pathway}{140}{subsection.5.1.1}
\contentsline {subsection}{\numberline {5.1.2}The Extracellular Matrix}{142}{subsection.5.1.2}
\contentsline {subsection}{\numberline {5.1.3}G Protein Coupled Receptors}{145}{subsection.5.1.3}
\contentsline {subsection}{\numberline {5.1.4}Gene Regulation and Translation}{145}{subsection.5.1.4}
\contentsline {section}{\numberline {5.2}Network Analysis of Synthetic Lethal Genes}{146}{section.5.2}
\contentsline {subsection}{\numberline {5.2.1}Gene Connectivity and Vertex Degree}{147}{subsection.5.2.1}
\contentsline {subsection}{\numberline {5.2.2}Gene Importance and Centrality}{148}{subsection.5.2.2}
\contentsline {subsubsection}{\numberline {5.2.2.1}Information Centrality}{148}{subsubsection.5.2.2.1}
\contentsline {subsubsection}{\numberline {5.2.2.2}PageRank Centrality}{150}{subsubsection.5.2.2.2}
\contentsline {section}{\numberline {5.3}Relationships between Synthetic Lethal Genes}{152}{section.5.3}
\contentsline {subsection}{\numberline {5.3.1}Hierarchical Pathway Structure}{152}{subsection.5.3.1}
\contentsline {subsubsection}{\numberline {5.3.1.1}Contextual Hierarchy of PI3K}{152}{subsubsection.5.3.1.1}
\contentsline {subsubsection}{\numberline {5.3.1.2}Testing Contextual Hierarchy of Synthetic Lethal Genes}{152}{subsubsection.5.3.1.2}
\contentsline {subsection}{\numberline {5.3.2}Upstream or Downstream Synthetic Lethality}{156}{subsection.5.3.2}
\contentsline {subsubsection}{\numberline {5.3.2.1}Measuring Structure of Candidates within PI3K}{156}{subsubsection.5.3.2.1}
\contentsline {subsubsection}{\numberline {5.3.2.2}Resampling for Synthetic Lethal Pathway Structure}{158}{subsubsection.5.3.2.2}
\contentsline {section}{\numberline {5.4}Discussion}{160}{section.5.4}
\contentsline {section}{\numberline {5.5}Summary}{162}{section.5.5}
\contentsline {chapter}{\numberline {6}Simulation and Modeling of Synthetic Lethal Pathways}{164}{chapter.6}
\contentsline {section}{\numberline {6.1}Synthetic Lethal Detection Methods}{165}{section.6.1}
\contentsline {subsection}{\numberline {6.1.1}Performance of SLIPT and $\chi ^2$ across Quantiles}{165}{subsection.6.1.1}
\contentsline {subsubsection}{\numberline {6.1.1.1}Correlated Query Genes affects Specificity}{169}{subsubsection.6.1.1.1}
\contentsline {subsection}{\numberline {6.1.2}Alternative Synthetic Lethal Detection Strategies}{171}{subsection.6.1.2}
\contentsline {subsubsection}{\numberline {6.1.2.1}Correlation for Synthetic Lethal Detection}{171}{subsubsection.6.1.2.1}
\contentsline {subsubsection}{\numberline {6.1.2.2}Testing for Bimodality with BiSEp}{173}{subsubsection.6.1.2.2}
\contentsline {section}{\numberline {6.2}Simulations with Graph Structures}{174}{section.6.2}
\contentsline {subsection}{\numberline {6.2.1}Performance over a Graph Structure}{175}{subsection.6.2.1}
\contentsline {subsubsection}{\numberline {6.2.1.1}Simple Graph Structures}{175}{subsubsection.6.2.1.1}
\contentsline {subsubsection}{\numberline {6.2.1.2}Constructed Graph Structures}{177}{subsubsection.6.2.1.2}
\contentsline {subsection}{\numberline {6.2.2}Performance with Inhibitions}{180}{subsection.6.2.2}
\contentsline {subsection}{\numberline {6.2.3}Synthetic Lethality across Graph Structures}{185}{subsection.6.2.3}
\contentsline {subsection}{\numberline {6.2.4}Performance within a Simulated Human Genome}{189}{subsection.6.2.4}
\contentsline {section}{\numberline {6.3}Simulations in More Complex Graph Structures}{193}{section.6.3}
\contentsline {subsection}{\numberline {6.3.1}Simulations over Pathway-based Graphs}{194}{subsection.6.3.1}
\contentsline {subsection}{\numberline {6.3.2}Pathway Structures in a Simulated Human Genome}{197}{subsection.6.3.2}
\contentsline {section}{\numberline {6.4}Discussion}{200}{section.6.4}
\contentsline {subsection}{\numberline {6.4.1}Simulation Procedure}{200}{subsection.6.4.1}
\contentsline {subsection}{\numberline {6.4.2}Comparing Methods with Simulated Data}{201}{subsection.6.4.2}
\contentsline {subsection}{\numberline {6.4.3}Design and Performance of SLIPT}{202}{subsection.6.4.3}
\contentsline {subsection}{\numberline {6.4.4}Simulations from Graph Structures}{204}{subsection.6.4.4}
\contentsline {section}{\numberline {6.5}Summary}{205}{section.6.5}
\contentsline {chapter}{\numberline {7}Discussion}{207}{chapter.7}
\contentsline {section}{\numberline {7.1}Synthetic Lethality and \textit {CDH1} Biology}{207}{section.7.1}
\contentsline {subsection}{\numberline {7.1.1}Established Functions of \textit {CDH1}}{208}{subsection.7.1.1}
\contentsline {subsection}{\numberline {7.1.2}The Molecular Role of \textit {CDH1} in Cancer}{208}{subsection.7.1.2}
\contentsline {section}{\numberline {7.2}Significance}{209}{section.7.2}
\contentsline {subsection}{\numberline {7.2.1}Synthetic Lethality in the Genomic Era}{209}{subsection.7.2.1}
\contentsline {subsection}{\numberline {7.2.2}Clinical Interventions based on Synthetic Lethality}{211}{subsection.7.2.2}
\contentsline {section}{\numberline {7.3}Future Directions}{212}{section.7.3}
\contentsline {section}{\numberline {7.4}Conclusions}{214}{section.7.4}
\contentsline {chapter}{\hbox to\@tempdima {\hfil }References}{216}{subsubsection.3.5.3.5}
\contentsline {chapter}{\numberline {A}Sample Quality}{240}{appendix.A}
\contentsline {section}{\numberline {A.1}Sample Correlation}{240}{section.A.1}
\contentsline {section}{\numberline {A.2}Replicate Samples in TCGA Breast}{243}{section.A.2}
\contentsline {chapter}{\numberline {B}Software Used for Thesis}{247}{appendix.B}
\contentsline {chapter}{\numberline {C}Mutation Analysis in Breast Cancer}{256}{appendix.C}
\contentsline {section}{\numberline {C.1}Synthetic Lethal Genes and Pathways}{256}{section.C.1}
\contentsline {section}{\numberline {C.2}Synthetic Lethal Expression Profiles}{259}{section.C.2}
\contentsline {section}{\numberline {C.3}Comparison to Primary Screen}{262}{section.C.3}
\contentsline {subsection}{\numberline {C.3.1}Resampling Analysis}{264}{subsection.C.3.1}
\contentsline {section}{\numberline {C.4}Compare SLIPT genes}{266}{section.C.4}
\contentsline {section}{\numberline {C.5}Metagene Analysis}{268}{section.C.5}
\contentsline {section}{\numberline {C.6}Expression of Somatic Mutations}{269}{section.C.6}
\contentsline {section}{\numberline {C.7}Metagene Expression Profiles}{272}{section.C.7}
\contentsline {chapter}{\numberline {D}Intrinsic Subtyping}{275}{appendix.D}
\contentsline {chapter}{\numberline {E}Stomach Expression Analysis}{277}{appendix.E}
\contentsline {section}{\numberline {E.1}Synthetic Lethal Genes and Pathways}{277}{section.E.1}
\contentsline {section}{\numberline {E.2}Comparison to Primary Screen}{281}{section.E.2}
\contentsline {subsection}{\numberline {E.2.1}Resampling Analysis}{283}{subsection.E.2.1}
\contentsline {section}{\numberline {E.3}Metagene Analysis}{285}{section.E.3}
